Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Cardiovascular Diagnosis and Therapy
|
November 28, 2013
Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software
Pavel Goykhman, Puja K Mehta, Megha Agarwal, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 4, 2021
Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations
Xinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.
Frontiers in Physiology
|
December 19, 2012
Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches
Sudin Bhattacharya, Lisl K M Shoda, Qiang Zhang, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Model-Informed Drug Development in Pediatric Dose Selection
Youwei Bi, Jiang Liu, Fang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2023
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Deepti Telaraja, Yvette L Kasamon, Justin S Collazo, et al.
JACC. Cardiovascular Imaging
|
May 14, 2011
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease
Puja K Mehta, Pavel Goykhman, Louise E J Thomson, et al.
Pharmacology Research & Perspectives
|
October 19, 2019
Quantitative systems toxicology (QST) reproduces species differences in PF-04895162 liver safety due to combined mitochondrial and bile acid toxicity
Grant Generaux, Vinal V Lakhani, Yuching Yang, et al.
Menopause (New York, N.Y.)
|
May 3, 2011
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
Chrisandra L Shufelt, B Delia Johnson, Sarah L Berga, et al.
JACC. Cardiovascular Imaging
|
January 15, 2011
Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus
Mariko L Ishimori, Rebecca Martin, Daniel S Berman, et al.
Journal of Women'S Health (2002)
|
August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)
C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Cardiovascular Diagnosis and Therapy
|
November 28, 2013
Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software
Pavel Goykhman, Puja K Mehta, Megha Agarwal, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 4, 2021
Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations
Xinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.
Frontiers in Physiology
|
December 19, 2012
Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches
Sudin Bhattacharya, Lisl K M Shoda, Qiang Zhang, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Model-Informed Drug Development in Pediatric Dose Selection
Youwei Bi, Jiang Liu, Fang Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2023
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Deepti Telaraja, Yvette L Kasamon, Justin S Collazo, et al.
JACC. Cardiovascular Imaging
|
May 14, 2011
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease
Puja K Mehta, Pavel Goykhman, Louise E J Thomson, et al.
Pharmacology Research & Perspectives
|
October 19, 2019
Quantitative systems toxicology (QST) reproduces species differences in PF-04895162 liver safety due to combined mitochondrial and bile acid toxicity
Grant Generaux, Vinal V Lakhani, Yuching Yang, et al.
Menopause (New York, N.Y.)
|
May 3, 2011
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
Chrisandra L Shufelt, B Delia Johnson, Sarah L Berga, et al.
JACC. Cardiovascular Imaging
|
January 15, 2011
Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus
Mariko L Ishimori, Rebecca Martin, Daniel S Berman, et al.
Journal of Women'S Health (2002)
|
August 26, 2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)
C Noel Bairey Merz, B Delia Johnson, Sarah L Berga, et al.
Page
of 5